OPEN LABEL SINGLE CENTRIC CLINICAL EXPLORATORY OF EFFICACY STUDY ON DELIPO CAPSULE, AN AYURVEDIC PROPRIETARY FORMULATION

Introduction: Obesity and hypercholesterolemia are significant global health concerns, contributing to metabolic disorders such as cardiovascular disease and type 2 diabetes. Conventional treatments often include pharmacological interventions and lifestyle modifications, which may have limitations in terms of adherence and side effects. Ayurvedic medicine offers a holistic approach to weight management and metabolic regulation. DELIPO CAPSULE, a proprietary Ayurvedic formulation, has been developed to address symptoms associated with obesity, including shortness of breath, fatigue, excessive sweating,, difficulty in sleeping and high LDL cholesterol levels. Objective: The primary objective of this study was to evaluate the clinical efficacy of DELIPO CAPSULE in managing symptoms of obesity and hypercholesterolemia. Methods: The study aimed to assess its impact on weight management, cholesterol levels, and associated symptoms over a 30-day treatment period. This Phase-IIA, single-center, open-label, therapeutic exploratory clinical trial was conducted on 20 patients diagnosed with obesity-related conditions. Participants were administered 1-2 DELIPO CAPSULES twice daily with lukewarm water for 30 days. Clinical and laboratory assessments were performed at baseline (day-1) and post-treatment (day-30). Ethical approval was obtained, and written informed consent was secured from all participants. Results: After 30 days of treatment: 75% (15 patients) experienced significant symptom improvement. 15% (3 patients) showed moderate improvement. 5% (1 patient) had mild improvement. 5% (1 patient) dropped out of the study. Laboratory investigations confirmed improvements in cholesterol levels and metabolic markers. Conclusion: DELIPO CAPSULE demonstrated significant efficacy in managing obesity-related symptoms and metabolic imbalances. The findings support its potential as a safe and effective Ayurvedic intervention for weight management and hypercholesterolemia.

Authors

Publication Details

Journal
International Journal of Medical and Exercise Science
Published
2025-01-01
DOI
https://doi.org/10.36678/ijmaes.2025.v10i01.002
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OPEN LABEL SINGLE CENTRIC CLINICAL EXPLORATORY OF EFFICACY STUDY ON DELIPO CAPSULE, AN AYURVEDIC PROPRIETARY FORMULATION

Sumit Kumar Suman, Padmanabhan Karthikeyan, Subbaramiah Sridhar, B. Devendran et al.
International Journal of Medical and Exercise Science
Phytochemicals and Medicinal Plants
article

OPEN LABEL SINGLE CENTRIC CLINICAL EXPLORATORY OF EFFICACY STUDY ON DELIPO CAPSULE, AN AYURVEDIC PROPRIETARY FORMULATION

Sumit Kumar Suman, Padmanabhan Karthikeyan, Subbaramiah Sridhar, B. Devendran, S. Moulishankar, G. Raaja, G.S. Aathithiah, M. Vetriselvan, Joemon, R. Pachiyappan
article en

Abstract

Introduction: Obesity and hypercholesterolemia are significant global health concerns, contributing to metabolic disorders such as cardiovascular disease and type 2 diabetes. Conventional treatments often include pharmacological interventions and lifestyle modifications, which may have limitations in terms of adherence and side effects. Ayurvedic medicine offers a holistic approach to weight management and metabolic regulation. DELIPO CAPSULE, a proprietary Ayurvedic formulation, has been developed to address symptoms associated with obesity, including shortness of breath, fatigue, excessive sweating,, difficulty in sleeping and high LDL cholesterol levels. Objective: The primary objective of this study was to evaluate the clinical efficacy of DELIPO CAPSULE in managing symptoms of obesity and hypercholesterolemia. Methods: The study aimed to assess its impact on weight management, cholesterol levels, and associated symptoms over a 30-day treatment period. This Phase-IIA, single-center, open-label, therapeutic exploratory clinical trial was conducted on 20 patients diagnosed with obesity-related conditions. Participants were administered 1-2 DELIPO CAPSULES twice daily with lukewarm water for 30 days. Clinical and laboratory assessments were performed at baseline (day-1) and post-treatment (day-30). Ethical approval was obtained, and written informed consent was secured from all participants. Results: After 30 days of treatment: 75% (15 patients) experienced significant symptom improvement. 15% (3 patients) showed moderate improvement. 5% (1 patient) had mild improvement. 5% (1 patient) dropped out of the study. Laboratory investigations confirmed improvements in cholesterol levels and metabolic markers. Conclusion: DELIPO CAPSULE demonstrated significant efficacy in managing obesity-related symptoms and metabolic imbalances. The findings support its potential as a safe and effective Ayurvedic intervention for weight management and hypercholesterolemia.

International Journal of Medical and Exercise ScienceVol. 11(01)
Openalex Percentile: Top 92%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.